This job is closed
Applications are no longer available for this announcement. Explore current related opportunities below.
Job description
Alnylam Pharmaceuticals seeks a Global Medical Director, Early Assets to develop, lead, and execute the medical strategy for CNS early-stage programs including Huntington’s disease, CAA, and Alzheimer's disease.
You will serve as the medical affairs delegate on the Program Team, driving evidence generation, thought leadership, and scientific engagement with international stakeholders to support development and commercialization plans.
#J-18808-Ljbffr
Worksite address
cambridge, MA, 02140, US
Who can apply
Review the original listing for work authorization, qualifications and employer requirements.